NIZORAL

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, UK.

Active ingredients

The drug NIZORAL contains one active pharmaceutical ingredient (API):

1
UNII R9400W927I - KETOCONAZOLE
 

Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes.

 
Read more about Ketoconazole

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 NIZORAL Shampoo MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D01AC08 Ketoconazole D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 1574W, 9024Y
BR Câmara de Regulação do Mercado de Medicamentos 514502603161319
CA Health Products and Food Branch 02182920
DE Bundesinstitut für Arzneimittel und Medizinprodukte 03265207, 03265213, 09289628, 09289640, 13889819, 13889825
EE Ravimiamet 1018189, 1060940, 1060951, 1060984, 1821204, 1843736, 1850116
FI Lääkealan turvallisuus- ja kehittämiskeskus 393957, 454689, 522237
GB Medicines & Healthcare Products Regulatory Agency 27623, 27655, 27660, 377406, 381563, 80674
HK Department of Health Drug Office 31551
IE Health Products Regulatory Authority 46094, 76333, 76350
IL מִשְׂרַד הַבְּרִיאוּת 1397, 2491
JP 医薬品医療機器総合機構 2655709N1053, 2655709Q1025
LT Valstybinė vaistų kontrolės tarnyba 1013162, 1014156, 1063038, 1066508, 1070167, 1075377, 1075481, 1082478, 1083391, 1089259, 1091909, 1092604, 1093129, 1093130
MT Medicines Authority MA830/00401, MA830/00402, PI1438/07301A, PI521/08402A, PI908/06601A
MX Comisión Federal para la Protección contra Riesgos Sanitarios 209M83, 295M89, 94M83
NG Registered Drug Product Database 04-1733, 04-1734
Switch country to Nigeria in order to find specific presentations of NIZORAL
NL Z-Index G-Standaard 12811599
NL Z-Index G-Standaard, PRK 23264
NZ Medicines and Medical Devices Safety Authority 3393, 3394, 3395
PL Rejestru Produktów Leczniczych 100047790, 100047808, 100260710, 100260761, 100264687, 100266812, 100292318, 100327459, 100353630, 100356892, 100363202, 100366264, 100368122, 100413905, 100451660
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W57514001, W57514002
SG Health Sciences Authority 01117P, 04926P
US FDA, National Drug Code 50458-680

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.